Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02994979 · ClinicalTrials.gov registry record · NA

Nursing Assistant Intervention to Prevent Delirium in Nursing Homes

A NA study of Delirium, sponsored by Jewish Home & Hospital Lifecare System.

Completed
Registry status
NA
Development phase
219
Enrollment target
1
Study location

NCT02994979: Completed NA study of Delirium, sponsored by Jewish Home & Hospital Lifecare System.

NCT02994979 is a NA study of Delirium that has completed, run by Jewish Home & Hospital Lifecare System. The registered enrollment target is 219 participants, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02994979, a NA study of Delirium, has completed, sponsored by Jewish Home & Hospital Lifecare System.

COMPLETED
Registry status
NA
Development phase
219 participants
Enrollment target
1
Study location

Study Summary

Delirium is an acute confusion that occurs in one third of hospitalized older adults. As compared to those without delirium, hospitalized patients with delirium have longer hospital stays, higher mortality, and increased risk of nursing home utilization. Substantial attention has been paid to developing, testing, and disseminating interventions to prevent delirium in the hospital but, to date, not in the nursing home setting. In a previous study we used known information on delirium risk factors to develop an intervention that can be delivered at onset of acute illness in nursing home patients. The current study is designed to test the effect of this intervention in a single-site clinical trial. Objectives: 1) to determine, as compared to control, the effect of a multicomponent intervention targeting delirium risk factors on delirium frequency, delirium severity, cognitive and physical function decline, and hospitalization in nursing home patients with acute illness, and 2) to identify features of the intervention associated with occurrence of delirium and other outcomes. Approach: We will screen nursing home patients on 17 long-term care units at a large, urban nursing home who experience onset of a change in condition according to established criteria, and enroll and assign them to intervention or control in a 1:1 ratio. Those assigned to intervention will receive daily visits from an Elder Life Specialist, a mobile Certified Nursing Assistant trained to provide services to counter risks for delirium, including dehydration, immobility, cognitive impairment, undernutrition, and sleep problems, for the duration of the acute illness and for 1 week following. Patients assigned to control will receive usual care from the unit-based nurses and the patient's primary team. Delirium will be assessed 5 days a week by a research assistant. Cognitive and physical function decline and hospital transfer will be ascertained during a 1 month follow-up period. We will compare outc

Primary Outcome

Confusion Assessment Method (CAM)

Conditions Studied

Interventions

  • OTHER Sham comparator
  • OTHER Delirium-prevention

Study Locations (1)

New York

  • The New Jewish Home - New York

Trial Details

FieldValue
Enrollment Target 219 participants
Start Date 2016-11
Est. Completion 2018-08-28
Phase NA

What the finished NCT02994979 record still lists

NCT02994979 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 2 interventions - of which Sham comparator is the first listed.

NCT02994979 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02994979 about?

NCT02994979 is a clinical study titled "Nursing Assistant Intervention to Prevent Delirium in Nursing Homes". Delirium is an acute confusion that occurs in one third of hospitalized older adults. As compared to those without delirium, hospitalized patients with delirium have longer hospital stays, higher mortality, and increased risk of nursing home utilization. Substantial attention has been paid to develo...

What is the current status of trial NCT02994979?

This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2016-11. Estimated completion is 2018-08-28.

What conditions does trial NCT02994979 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT02994979?

The interventions under investigation include: Sham comparator (OTHER), Delirium-prevention (OTHER).

Who is sponsoring clinical trial NCT02994979?

This trial is sponsored by Jewish Home & Hospital Lifecare System, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02994979 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02994979's enrollment target sits among peer trials

219 27th of 62 higher than 36 of 62 other Delirium trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05196035 · 219 participants · Phase 3

    A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

  • NCT05608434 · 219 participants · Phase 1

    Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

  • NCT05773144 · 219 participants · NA

    Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

  • NCT05907980 · 219 participants · Phase 1

    A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02994979, the US trial registry maintained by the National Library of Medicine. NCT02994979 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.